FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2136935856> ?p ?o ?g. }

• W2136935856 endingPage "782" @default.
• W2136935856 startingPage "766" @default.
• W2136935856 abstract "The basis of resistance to oxidative injury was studied in six murine tumor cell lines that differed 54-fold in their resistance to enzymatically generated H(2)0(2). The tumors varied 56.7-fold in their specific activity of catalase, 5.3-fold in glutathione peroxidase (GPO), 3.3-fold in glutathione reductase (GR), and 2.7-fold in glutathione. There was no correlation among the levels of the three enzymes, and tumor cell resistance to lysis by H(2)0(2). However, the logarithm of the flux of H(2)0(2) necessary to cause 50 percent lysis of the tumor cells correlated with their content of glutathione (r = 0.91). The protective role of glutathione was analyzed by blocking GR and GPO, the catalysts of the glutathione redox cycle. This was facilitated by the demonstration that the anti-neoplastic agent 1,3-bis-(2- chloroethyl)-l-nitrosourea (BCNU) was a potent inhibitor of GR in intact tumor cells. BCNU inactivated tumor cell GR with a 50 percent inhibitory dose of 11 muM and a t(l/2) of inhibition of 30 s. Complete inhibition of GR was attained with no effect on GPO or catalase. Tumor cells whose GR was inactivated by BCNU could be lysed by fluxes of H(2)0(2) to which they were otherwise completely resistant. They could be killed by phorbol myristate acetate (PMA)-stimulated, bacilli Calmette-Guerin-activated macrophages in numbers which were otherwise insufficient, and by nonactivated macrophages, which otherwise were ineffective. BCNU-treated target cells were also much more sensitive to antibody-dependent, macrophage-mediated cytolysis. However, such tumor cells were no more sensitive than controls to lysis by alloreactive T cells or by antibody plus complement. Next, we deprived tumor cells of selenium by passage in selenium-deficient mice. GPO was inhibited 85 percent in such cells, with no effect on GR or catalase. Tumor cells with reduced GPO activity were markedly sensitized to lysis by small fluxes of H(2)0(2) or by PMA-stimulated macrophages or granulocytes. In contrast, inhibition of catalase with aminotriazole had no effect on the sensitivity of three tumors to peroxide-mediated lysis, and had modest effects with two others. Thus, the oxidation-reduction cycle of glutathione serves as one of the major defense mechanisms of tumor cells against three related forms of oxidant injury: lysis by fluxes of H(2)0(2), by PMA-triggered macrophages, and by macrophages in the presence of anti-tumor antibody." @default.
• W2136935856 created "2016-06-24" @default.
• W2136935856 creator A5021771725 @default.
• W2136935856 creator A5034857709 @default.
• W2136935856 creator A5042059914 @default.
• W2136935856 creator A5046224237 @default.
• W2136935856 creator A5071173863 @default.
• W2136935856 date "1981-04-01" @default.
• W2136935856 modified "2023-09-27" @default.
• W2136935856 title "Tumor cell anti-oxidant defenses. Inhibition of the glutathione redox cycle enhances macrophage-mediated cytolysis" @default.
• W2136935856 cites W1511013913 @default.
• W2136935856 cites W1535828429 @default.
• W2136935856 cites W1543929787 @default.
• W2136935856 cites W1544551687 @default.
• W2136935856 cites W1581414347 @default.
• W2136935856 cites W1775749144 @default.
• W2136935856 cites W1776917887 @default.
• W2136935856 cites W1920198420 @default.
• W2136935856 cites W1975928614 @default.
• W2136935856 cites W1983678579 @default.
• W2136935856 cites W1984271271 @default.
• W2136935856 cites W1990276581 @default.
• W2136935856 cites W1992087911 @default.
• W2136935856 cites W1994306318 @default.
• W2136935856 cites W1997297528 @default.
• W2136935856 cites W2006058262 @default.
• W2136935856 cites W2007064404 @default.
• W2136935856 cites W2009082798 @default.
• W2136935856 cites W2055736386 @default.
• W2136935856 cites W2086896885 @default.
• W2136935856 cites W2093560859 @default.
• W2136935856 cites W2098621632 @default.
• W2136935856 cites W2101518804 @default.
• W2136935856 cites W2111047750 @default.
• W2136935856 cites W2136589539 @default.
• W2136935856 cites W2158801729 @default.
• W2136935856 cites W2161057260 @default.
• W2136935856 cites W2169130110 @default.
• W2136935856 cites W2171070360 @default.
• W2136935856 cites W2258452643 @default.
• W2136935856 cites W2304333754 @default.
• W2136935856 cites W2314062201 @default.
• W2136935856 cites W2315737152 @default.
• W2136935856 cites W2322820872 @default.
• W2136935856 cites W2343845227 @default.
• W2136935856 cites W2440140994 @default.
• W2136935856 cites W46996808 @default.
• W2136935856 doi "https://doi.org/10.1084/jem.153.4.766" @default.
• W2136935856 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2186135" @default.
• W2136935856 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7252413" @default.
• W2136935856 hasPublicationYear "1981" @default.
• W2136935856 type Work @default.
• W2136935856 sameAs 2136935856 @default.
• W2136935856 citedByCount "210" @default.
• W2136935856 countsByYear W21369358562012 @default.
• W2136935856 countsByYear W21369358562013 @default.
• W2136935856 countsByYear W21369358562014 @default.
• W2136935856 countsByYear W21369358562015 @default.
• W2136935856 countsByYear W21369358562016 @default.
• W2136935856 countsByYear W21369358562017 @default.
• W2136935856 countsByYear W21369358562021 @default.
• W2136935856 countsByYear W21369358562022 @default.
• W2136935856 crossrefType "journal-article" @default.
• W2136935856 hasAuthorship W2136935856A5021771725 @default.
• W2136935856 hasAuthorship W2136935856A5034857709 @default.
• W2136935856 hasAuthorship W2136935856A5042059914 @default.
• W2136935856 hasAuthorship W2136935856A5046224237 @default.
• W2136935856 hasAuthorship W2136935856A5071173863 @default.
• W2136935856 hasBestOaLocation W21369358561 @default.
• W2136935856 hasConcept C109316439 @default.
• W2136935856 hasConcept C153911025 @default.
• W2136935856 hasConcept C165069038 @default.
• W2136935856 hasConcept C181199279 @default.
• W2136935856 hasConcept C185592680 @default.
• W2136935856 hasConcept C202751555 @default.
• W2136935856 hasConcept C2776151105 @default.
• W2136935856 hasConcept C2778760513 @default.
• W2136935856 hasConcept C2778979269 @default.
• W2136935856 hasConcept C538909803 @default.
• W2136935856 hasConcept C55493867 @default.
• W2136935856 hasConcept C57409179 @default.
• W2136935856 hasConcept C73588182 @default.
• W2136935856 hasConcept C86803240 @default.
• W2136935856 hasConceptScore W2136935856C109316439 @default.
• W2136935856 hasConceptScore W2136935856C153911025 @default.
• W2136935856 hasConceptScore W2136935856C165069038 @default.
• W2136935856 hasConceptScore W2136935856C181199279 @default.
• W2136935856 hasConceptScore W2136935856C185592680 @default.
• W2136935856 hasConceptScore W2136935856C202751555 @default.
• W2136935856 hasConceptScore W2136935856C2776151105 @default.
• W2136935856 hasConceptScore W2136935856C2778760513 @default.
• W2136935856 hasConceptScore W2136935856C2778979269 @default.
• W2136935856 hasConceptScore W2136935856C538909803 @default.
• W2136935856 hasConceptScore W2136935856C55493867 @default.
• W2136935856 hasConceptScore W2136935856C57409179 @default.
• W2136935856 hasConceptScore W2136935856C73588182 @default.
• W2136935856 hasConceptScore W2136935856C86803240 @default.
• W2136935856 hasIssue "4" @default.

• next